今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

油价今晚下调！92号汽油重回“7元时代”，加满一箱省7.5元

北京，2024年6月14日 - 备受期待的油价调整终于来了！根据国家发改委消息，新一轮成品油调价窗口于昨晚（6月13日）24时开启，国内汽油、柴油零售限价迎来年内第二次下调。

本次下调幅度为每吨汽油下调190元，柴油下调180元。据国家发展改革委价格监测中心监测，本轮成品油调价周期内（5月29日—6月12日）国际油价呈现震荡下行趋势。平均而言，原油进口价格下降9.63%，成产品价格下降7.05%。

调价落地后，除海南省和西南部分高价区外，国内多数地区92号汽油零售价格将重回“7元时代”。按照油箱容量为50升的家用轿车计算，加满一箱92号汽油将节省约7.5元。

这是今年以来国内成品油价格的第二次下调，也是年内首次汽柴油价格同步下调。此前，国家发改委于3月28日宣布下调汽柴油零售价格，汽油每吨下调130元，柴油每吨下调125元。

业内人士分析认为，近期国际油价下跌主要受以下因素影响：一是全球经济增速放缓，抑制了原油需求；二是美国页岩油产量持续增长，供应充足；三是国际市场炒作减少，避险情绪减弱。

当前，国内成品油价格联动机制和完善价格形成机制改革工作正在稳步推进。按照改革方案，新机制将以市场为主、价格联动为原则，综合考虑国际市场价格变化、国内供需状况和成本等因素，形成成品油价格。

专家表示，未来国际油价走势仍存在较多不确定性，国内成品油价格也将相应调整。